Should You Start Antiviral Therapy?
Yes, you should start oral antiviral therapy immediately, even though the rash timing is uncertain—the one week of pain alone warrants treatment for presumed herpes zoster, as pain often precedes the rash and early treatment (ideally within 72 hours of rash onset) significantly reduces complications including postherpetic neuralgia.
Clinical Context and Rationale
The scenario you describe—pain for one week with uncertain rash onset—is actually a classic presentation of herpes zoster. The pain typically precedes the characteristic dermatomal rash by several days 1, 2. This creates a diagnostic and therapeutic dilemma: the patients who would benefit most from antiviral therapy often cannot be definitively diagnosed until the rash appears, by which time the optimal treatment window may be closing 1.
Treatment Window: The 72-Hour Rule
The critical treatment window is within 72 hours of rash onset 3, 2, 4, 5. Antiviral therapy started within this timeframe:
- Shortens the duration of acute pain and virus shedding
- Reduces the severity and duration of the rash
- Decreases the incidence and severity of postherpetic neuralgia (PHN)
- Prevents acute and late-onset complications 3
Important caveat: While the 72-hour window is emphasized in guidelines, this doesn't mean treatment is futile beyond this point. If you're uncertain about when the rash started, err on the side of treatment—particularly given your week-long pain history.
Recommended Antiviral Regimens
Choose one of the following 3, 2, 4:
First-line options:
- Valacyclovir 1 g orally three times daily for 7 days
- Famciclovir 500 mg orally three times daily for 7 days
- Acyclovir 800 mg orally five times daily for 7-10 days
Valacyclovir and famciclovir offer better bioavailability and more convenient dosing compared to acyclovir, though all three are equally effective 4.
Who Absolutely Needs Treatment
Urgent indications (treat immediately) 4:
- Age >50 years (regardless of location)
- Herpes zoster in the head/neck area at any age
- Zoster ophthalmicus (ophthalmic involvement)
- Immunocompromised patients
- Severe disease on trunk or extremities
Relative indications (consider treatment):
- Age <50 years with trunk or extremity involvement
Given your one-week pain history, you likely fall into a category warranting treatment.
Pain Management: The Primary Goal
The most important aim is achieving painlessness 4. Antiviral therapy alone is insufficient for pain control. You need:
Acute pain management:
- Appropriately dosed analgesics (NSAIDs initially, opioids if needed)
- Plus a neuroactive agent: amitriptyline 25-75 mg at bedtime 4, 5
- Consider pregabalin 75-150 mg twice daily for neuropathic pain 5
Corticosteroids: May shorten acute pain duration but do NOT prevent postherpetic neuralgia 4. Use is optional and not routinely recommended.
Critical Red Flags Requiring Immediate Referral
Refer to ophthalmology immediately if 2:
- Rash involves the tip of the nose (Hutchinson's sign)
- Any eye pain, vision changes, or periorbital involvement
- Ocular complications can be serious and vision-threatening
Refer to emergency department if:
- Signs of disseminated infection
- Neurological symptoms (confusion, severe headache, weakness)
- Immunocompromised status with severe disease
Common Pitfalls to Avoid
- Waiting for definitive rash appearance: Don't delay treatment if clinical suspicion is high based on dermatomal pain pattern
- Dismissing the 72-hour window as absolute: Late treatment still provides benefit, especially for pain reduction
- Treating with antivirals alone: Pain management is equally critical and often overlooked
- Missing ophthalmic involvement: Always examine for eye involvement in facial zoster
The Evidence Landscape
The provided guidelines focus primarily on genital herpes simplex virus [6-7], which is not relevant to your question about herpes zoster. The pertinent evidence comes from research studies on herpes zoster management 3, 2, 4, 8, 5, 9. These consistently demonstrate that oral antivirals (acyclovir, valacyclovir, famciclovir) are effective when started within 72 hours of rash onset, with the primary goals being reduction of acute complications and prevention of postherpetic neuralgia—a debilitating chronic pain condition affecting 10-20% of patients overall and up to 50% of those over age 85 5.
Your Action Plan
- Start antiviral therapy today with one of the regimens above
- Begin pain management with combination therapy (analgesic + neuroactive agent)
- Examine carefully for any eye involvement
- Follow up in 48-72 hours to assess response
- If pain persists beyond 3 months, refer to pain specialist for PHN management